Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Azelastine 140micrograms/dose nasal spray |
| BNF code | 1202010A0AAABAB |
| Virtual Therapeutic Moiety | Azelastine |
| Date identifier became valid | 25 Aug 2023 |
| Previous product identifier | 331057004 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 25 Feb 2010 |
| Previous name | Azelastine 140micrograms/actuation nasal spray |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | actuation |
| Unit dose unit of measure | actuation |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Azelastine hydrochloride |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 140.000 |
| Strength value numerator unit | microgram |
| Strength value denominator | 1.000 |
| Strength value denominator unit | actuation |
| Ontology Drug Form & Route | |
| Form & Route | solutionspray.nasal |
| Dose Form | |
| Formulation | Spray |
| Drug Route | |
| Route | Nasal |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Rhinolast 140micrograms/dose nasal spray (Ceuta Healthcare Ltd) | |
| Rhinolast 140micrograms/dose nasal spray (Sigma Pharmaceuticals Plc) | |
| Virtual Medicinal Product Packs | |
| Azelastine 140micrograms/dose nasal spray 10 ml | |
| Azelastine 140micrograms/dose nasal spray 20 ml | |
| Azelastine 140micrograms/dose nasal spray 22 ml | |
| Azelastine 140micrograms/dose nasal spray 5 ml | |
dm+d data retrieved from TRUD: release NHSBSA_10.3.0_20251027000001, imported on 28th October 2025 at 04:07:32.